The Dissolution enhancement of Meloxicam tablets from the synergistic effect of hydrotropic and sublimating agent

Authors

Hemn L. Qader, Department of pharmaceutics, College of pharmacy, Hawler Medical University, Kurdistan Region, Iraq
Tara A. Abdula, Hawler Medical UniversityFollow
Huner K. Omer, Hawler Medical UniversityFollow

Corresponding Author

Hemn L. Qader

Authors ORCID

0000-0001-8817-7465

Document Type

Research Article

Abstract

Background and Objective: Drugs which fall into Class II of Biopharmaceutical Classification System suffer from poor aqueous solubility that limits the dissolution and oral bioavailability. The improvement of the dissolution rate of this class of drug is an important issue for enhancing their bioavailability and therapeutic efficacy. The objective of this study is to investigate the magnitude of enhancement of the dissolution rate of Class II drug “Meloxicam (MLX)” by using more than one solubility enhancement technique.

Keywords

Meloxicam, Solubility, Solid dispersion, Sublimation, camphor

How to Cite This Article

Qader, Hemn L.; Abdula, Tara A.; and Omer, Huner K. (2021) "The Dissolution enhancement of Meloxicam tablets from the synergistic effect of hydrotropic and sublimating agent," Polytechnic Journal: Vol. 11: Iss. 2, Article 16.
DOI: https://doi.org/10.25156/ptj.v11n2y2021.pp100-108

References

Al-Nima, A., M. Al-Kotaji and A. Khayrallah. 2014. Preparation and evaluation of meloxicam solid dispersions by solvent evaporation method. Int. Res. J. Pharm. 5(11): 838-845.

Ankita, D. and S. Yogesh. 2016. Solubility enhancement study of poorly absorbable. World J. Pharm. Res. 5(3): 933-964. Anna, K., K. Kyriakos and N. Ioannis. 2018. Co-amorphous solid dispersions for solubility and absorption improvement of drugs: Composition, preparation, characterization and formulations for oral delivery. Pharmaceutics. 10(3): e10030098.

Asaad, F., A. Sally and D. Ahmed. 2015. MCM-41 for meloxicam dissolution improvement: In vitro release and in vivo bioavailability studies. J. Braz. Chem. Soc. 26(7): 1367-1378.

Chauhan, Y. S. U. Kataria and A. Dashora. 2018. Formulation and evaluation of floating tablet for indomethacin. J. Drug Deliv. Ther. 8(4): 338-345.

Dhandapani, B., S. Eswara, N. Susrutha, S. Rama, R. Sonia, T. S. Sarath, G. Seetharamanjaneyulu, R. C. Baboo. 2010. Spectrophotometric estimation of meloxicam in bulk and its pharmaceutical formulations. Int. J. Pharm. Sci. Res. 1(4):217-221.

Dileep, K., K. Nagaraju, E. Chinna. 2012. Ormulation and evaluation of immediate release tablets containing anti platelet drugs. Int. Res. J. Pharm. Appl. Sci. 2(5): 170-179.

Hamsanandini, J., S. Parthiban, A. Vikneswari, G. P. Sentilkumar and T. T. Mani. 2015. Formulation and evaluation of Orodispersible liquisolid compacts of meloxicam using psyllium husk powder as a natural superdisintegrants. Int. J. Res. Pharm. Nano Sci. 4(2): 97-110.

Ibrahim, N. J., S. S. Smail, N. R. Hussein and T. A. Abdullah. 2020. Solubility enhancement of nimodipine using mixed hydrotropic solid dispersion technique. Zanco J. Med. Sci. 24(3): 386-394.

Iman, S., H. Metaq and Z. Sura. 2016. Formulation and in-vitro evaluation of fast dissolving tablets of meloxicam solid dispersion. Int. J. Pharm. Sci. Rev. Res. 41(1): 202-207.

Inayat, B., R. Prakash and K. Pritish. 2013. Formulation design and optimization of novel mouth dissolving tablets for venlafaxine hydrochloride using sublimation technique. J. Pharm. Res. 6: 593-598.

Jagtap, R. and S. Mohite. 2019. Meloxicam-pectin--cyclodextrin ternary complex by kneading for enhancement of solubility and dissolution rate. Asian J. Pharm. Clin. Res. 12(4): 189-194.

Jain, J., H. Bhavna, R. Mittal and P. Mandev. 2011. Formulation and evaluation of indomethacin bilayer sustained release tablets. Int. J. PharmTech. Res. 3(2): 1132-1138.

Kapadiya, N., I. Singhvi, K. Mehta, G. Karwani and J. Dhrubo. 2011. Hydrotropy: A promising tool for solubility enhancement: A review. Int. J. Drug Dev. Res. 3(2): 26-33.

Karthik, N., B. Vijaya and V. Sateesh. 2013. Different techniques to enhance the dissolution rate of Lovastatin: Formulation and evaluation. Asian J. Pharm. Clin. Res. 6(1): 56-60.

Kulkarni, S. V., R. P., Kumar, N. Patel, S. B. Rao, B. Ramesh and A. P. Kumar. 2011. Formulation and evaluation of fast disintigrating meloxicam tablets and its comparison with marketed product. Int. J. Pharm. Pharm. Sci. 3(1): 9193.

Mahavir, C., C. Atika, S. Anil, G. Saurabh and M. Shaily. 2012. New quantitative estimation of acetazolamide bulk sample using hydrotropic solubilizing agents. World J. Pharm. Res. 1(1): 50-57.

Malvey, S., N. Kshirasagar, V. Vishnu and J. Srikanth. 2015. Formulation and evaluation of acyclovir orodispersible tablets using sublimation method. J. Gen. Pract. 3(4): e1000208.

Margret, R., B. Debjit, Y. Rahul, B. Jayakar and K. Sampath. 2012. Formulation and evaluation the oral tablets ibuprofen. Pharm. Innov. 1(9): 32-43.

Mohamed, E., S. Mustafa, N. Aly and I. Assem. 2017. In vitro and in vivo evaluation of tablets containing meloxicam PEG 6000 ball-milled Co-ground mixture. J. Appl. Pharm. Sci. 7(3): 31-39.

Nabeela, S. and Z. Shahiq. 2018. Development of fast dissolving tablets of flurbiprofen by sublimation method and its in vitro evaluation development of fast dissolving tablets of flurbiprofen by sublimation method and its in vitro evaluation. Braz. J. Pharm. Sci. 54(4): e17061.

Nabeela, S. and Z. Shahiq. 2018. Development of fast dissolving tablets of flurbiprofen by sublimation method and its in vitro evaluation. Braz. J. Pharm. Sci. 54(4): e17061.

Narayan, K. 2018. Technologies to improve the solubility, dissolution and bioavailability of poorly soluble drugs. J. Anal. Pharm. Res. 7(1): e00198.

Ngwuluka, N., B. Idiakhoa, E. Nep, I. Ogaji and I. Okafor. 2010. Formulation and evaluation of paracetamol tablets manufactured using the dried fruit of Phoenix dactylifera Linn as an excipient. Res. Pharm. Biotech. 2(3): 25-32.

Pawan, S., Prevesh, K. and P. Neelkant. 2017. Formulation and evaluation of aspirin tablets by using different lubricants in combination for better kinetic drug release study by PCP. Res. J. Pharm. Technol. 10(9): 2934-2938.

Phuong, T., P. Yong-Chul, K. Dong-Hyun, L. Sang-Eun, K. Jin-Ki and P. Jeong-Sook. 2019. Overview of the manufacturing methods of solid dispersion technology for improving the solubility of poorly water-soluble drugs and application to anticancer drugs. Pharmaceutics. 11(3): 132.

Ravi, K., S. Palanichamy, M. Rajesh, R. Godwin, V. Anusha, N. Parasakthi and A. Thanga. 2010. Formulation and evaluation of orodispersible piroxicam tablets. J. Pharm. Sci. Res. 2(10): 615-621.

Shoormeij, Z., A. Taheri and A. Homayouni. 2018. Preparation and physicochemical characterization of meloxicam orally fast disintegration tablet using its solid dispersion. Braz. J. Pharm. 53(4): 176.

USP. 2008. The United States Pharmacopea. p2110-2114. Varun, R., L. Venkateshwarlu and L. Srikanth. 2010. Solubility enhancement techniques. Int. J. Pharm. Sci. Rev. Res. 5(1): 41-51.

Yellela, S. 2010. Pharmaceutical technologies for enhancing oral bioavailability of poorly soluble drugs. J. Bioequivalence Bioavailab. 2(2): 28-36.

Zahra, S., T. Azade and H. Alireza. 2017. Preparation and physicochemical characterization of meloxicam orally fast disintegration tablet using its solid dispersion. Braz. J. Pharm. Sci. 53(4): e00176.

Publication Date

12-30-2021